NASDAQ Archives - Page 3 of 6

Axcelis Technologies, Inc. Overbought in Morning Session

As of morning trading, Axcelis Technologies, Inc. (NASDAQ:$ACLS)’s current distance from 20-Day Simple Moving Average is 17.05%, standing 36.66% away from 50-Day Simple Moving Average while trading up 62.06% from the 200-Day Simple Moving Average. ... [Read]

Price Target Update on Spectrum Pharmaceuticals, Inc.

Oct 24 Jen Jiang

Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) plundered a cool -2.43% with the closing price of $18.90 as of morning trading. The overall volume in the last trading session was 2.7 million shares. ROI is a form of ... [Read]

SunPower Corporation Registers a 2.84% Price Change After Morning Session

Oct 24 Jen Jiang

As of morning trading, SunPower Corporation (NASDAQ:$SPWR) stock saw a move of 2.84% with the closing price of $6.87. During the past week, the company saw a total shift of 1.93%. Over the last three ... [Read]

Head-to-Head: Axcelis Technologies VS Xcerra Corporation

Oct 24 Dylan Bernhardt

When it comes to small-cap computer technology companies, Xcerra Corporation (NASDAQ:$XCRA) and Axcelis Technologies (NASDAQ:$ACLS) are two contenders. How do they stack up against each other, though? Let’s look at the stats of these two ... [Read]

Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter

Oct 24 Jen Jiang

According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales ... [Read]

Head-to-Head: Impax Laboratories VS. SCYNEXIS

Oct 24 Dylan Bernhardt

Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]